Somnomed finds UK distribution partner

By Dylan Bushell-Embling
Tuesday, 08 July, 2008

Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.

Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.

The UK is generally considered to be one of the most important sleep therapy markets in Europe.

Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.

Utilising networks of GPs across three states, a large-scale study intends on combining digital...

Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...

The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...

Content from other channels on our network

Mitigating unseen losses in large food packs

Perfect Automation and Omori have joined forces with packaging solutions

Fonterra names Richard Allen as new CEO

Food packaging testing supports Atlantic crossing victory

Seprify and BIOGRUND develop titanium dioxide-free tablet coating for nutraceuticals

Ensuring reliable level measurement in tanks with internal obstructions

Australia and US investing in additional critical minerals projects

How to centralise remote access: securing all access to your OT systems

Shining a light on cyber threats hiding on the plant floor

AI system learns to keep warehouse robot traffic running smoothly

National Pain Alliance launched to advocate for chronic pain

Sexual misconduct findings added to public register under "landmark reforms"

Australia invests further $14.6 million in national allergy research

Can seasonal influenza vaccination prime the immune system for future strains?

"Targeted supports" launched for former patients of Simon Gordon